Dr Reddy’s wins FDA approval for dementia drug

Indian-based pharmaceutical company Dr Reddy's Laboratories has announced that its US subsidiary has received tentative approval from the FDA for galantamine hydrobromide tablets in the strengths of 4mg, 8mg and 12mg.